Efficacy and Safety of Tocilizumab Treatment in Tunisian Critically Ill COVID-19 Patients

Efficacy and Safety of Tocilizumab Treatment in Tunisian Critically Ill COVID-19 Patients

Background. COVID-19 is the major cause of serious acute respiratory complications, leading to strong perturbation of cytokine release and high levels of interleukin-6. In this work, we assessed the efficacy and safety of Tocilizumab in Tunisian patients with severe COVID-19. Materials and Methods....

Full description

Saved in:
Bibliographic Details
Main Authors: Khadija Bahrini, Hamza Ben Cheikh Larbi, Mouna Ben Azaiez, Nejla Stambouli, Mohamed Zakraoui, Sana Boughariou, Mohamed Ali Yousfi, Iheb Labbene, Mayssa Daiki, Hédi Gharsallah, Chihebeddine Romdhani, Mustapha Ferjani
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2024/2585821
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://dx.doi.org/10.1155/2024/2585821

Similar Items